{"name":"Nyrada Pty Ltd","slug":"nyrada-pty-ltd","ticker":"","exchange":"","domain":"nyradapty.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Xolatryp","genericName":"Xolatryp","slug":"xolatryp","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Xolatryp","genericName":"Xolatryp","slug":"xolatryp","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-02-06","type":"earnings","source":"simplywall.st","summary":"Despite currently being unprofitable, Nyrada (ASX:NYR) has delivered a 776% return to shareholders over 1 year - simplywall.st","headline":"Despite currently being unprofitable, Nyrada (ASX:NYR) has delivered a 776% return to shareholders over 1 year","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-25","type":"deal","source":"simplywall.st","summary":"Nyrada Insiders May Regret Not Buying More, Market Cap Hits AU$207m - simplywall.st","headline":"Nyrada Insiders May Regret Not Buying More, Market Cap Hits AU$207m","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-20","type":"pipeline","source":"simplywall.st","summary":"Nyrada Inc.'s (ASX:NYR) stock price dropped 10% last week; individual investors would not be happy - simplywall.st","headline":"Nyrada Inc.'s (ASX:NYR) stock price dropped 10% last week; individual investors would not be happy","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-23","type":"earnings","source":"simplywall.st","summary":"Nyrada Full Year 2025 Earnings: AU$0.024 loss per share (vs AU$0.009 loss in FY 2024) - simplywall.st","headline":"Nyrada Full Year 2025 Earnings: AU$0.024 loss per share (vs AU$0.009 loss in FY 2024)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOSzUwRlZ1eHlpa0YteVdvV2FVeUg2ZU41NUZmZkFpcW9seDE4YzJPdDE4emFJQ0FpbVcyQWhnckZTMS1INGZGSm9uSnRUUjVTcHAwbURpX0Zyc3BkVGtSTTFRWG5VRFoyX3NHUzQ2bzE3cDBlaUZiVHFXaVdHZkF3NnY5V0RQNlpXNVRTZGozaXRHT2NwWWZLQTJJb3R4NGI5WmN5X25ONVhVc3JoazEtU2tsV2dvVFkzU0t0b0dUNzRtdE0tdXM5cU1kWkpJeTFScFVfWHIzOTXSAd4BQVVfeXFMTnFlZEE0MXV2YV9HZ0tIYnBrQklsZ2xTRmR4TmlGNFNqcEJ2RkZSb3JLVWZBTF9IUE1OMHZOWlA3ZnhEZWktanJRaU8xbWZlTUJiOHg0Y1FQVzBiVE5vWTk3UzJDQW5EQXhSUmlWMm1Mb3NYZGV6UWVNU2JvbWNPblVHaTg5MjE4YVVBZHp3RVdDNzJ1VzVfNk9EWVY1UUdqUlE1RERDblMxaUEtR3NRdTNtb21nTENhR3IxOGZJcEtrak54LVZxSHAzT1lOQ0htQXlIRVNXNlJSSkVRNkpR?oc=5","date":"2025-07-02","type":"pipeline","source":"simplywall.st","summary":"Here's Why We're Watching Nyrada's (ASX:NYR) Cash Burn Situation - simplywall.st","headline":"Here's Why We're Watching Nyrada's (ASX:NYR) Cash Burn Situation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOTnU1YnY0VEh6SjBmTHZYYXktMXJtWnRya1U3alQzcFJ0VDQyX09YSlZ0MVpxdXVxbG9NbTNxeW5XOE5yTXpYbk5iNVBlWF9paWEyVVRadmt1cHYtWHJuMFRTa1FGZXRSSGxMM19ZR2JaZTlobDU4QmhhQ0VDcnlERlJxX0k4dUtjU1JDcjF1N0hqNWZwTm9BWUxlMkY3YWdDdEZNQlRTa3ZZY0RhNUx1M0ppZjdiMk9JT1FXU3dRcHlORjRrMWFNUmkycjRZNFlicDI4eEgxa2t3UkFZNDJIU0VZY29WbDQxMFM0Nl9yZWlncnBYeC05ZWladTU?oc=5","date":"2024-03-08","type":"pipeline","source":"NT News","summary":"Nyrada on the Neuren path, says CEO - NT News","headline":"Nyrada on the Neuren path, says CEO","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}